ArticleAntimicrobial agents and chemotherapy2021

Higher Dosing of Rifamycins Does Not Increase Activity against Mycobacterium tuberculosis in the Hollow-Fiber Infection Model.

E D Pieterman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.